The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
The worlds most expensive Fruitflow product.
Longevity med summit.
May 8-9 2024
"Science Shows Clinique La Prairie´s Anti-Ageing CLP Holistic Complex Works"
https://www.longevitymedsummit.com/clinique-la-prairie/
https://www.longevitymedsummit.com/simone-gibertoni/
https://cliniquelaprairie-hh.com/product/age-defy-regeneressence-and-immunity-supplements-2-x-120-capsules/
"Among the existing products, protein powder and Jianliduo have obtained new approvals"
The above 2 By-Health products are amongst their biggest revenue earners and already have Blue Cap so what could the new approvals include?
Is it 2 early to join the dots?????
"By-Health: Investor Relations Activity Record Form on April 11, 2024"
"Q: What new products can the company launch this year?"
A: "In August last year, in terms of new function development, the company took the lead in the industry to submit a new function application and product registration application that "helps maintain normal platelet aggregation function", and is currently actively promoting it. Among the existing products, protein powder and Jianliduo have obtained new approvals, and we strive to launch new products within the year."
Still pretty vague but I believe this is the first time By-Health have given any indication on timelines for a FF product.
https://data.eastmoney.com/notices/detail/300146/AN202404111630161330.html
BB,
You could be right and that's another possibility.
I would have thought that an RNS might have been required for such a "substantial transaction" but that could be classed as "in the ordinary course of business" so maybe not.
As alfista pointed out, until we get an update or the Y/E results its all pretty much guesswork.
Https://www.provexis.com/shareholder-information/major-shareholders/
Sphinx,
Its impossible to get an exact figure but should be able to get a more accurate figure when the year end results are released for YE 31/3/24. But even then we don't know if all the initial FF stock would have been sold by then.
For what its worth, this is what we know regarding sales.
Up to YE 31-3-23 £74k
First 6 months of this FY £299k
Next 1/4 to 31-12-23 £270k
and confirmed sales orders for Fruitflow II SD in excess of £320k were being processed as of 29-12-23
Alfista,
"Now, if we had also been notified that DSMV was the source of those sells, what would that have done to morale and the sp? Has ignorance been bliss?"
Your right, it probably has been but the rules are designed to enhance market transparency and failure to
comply with the rules risks damaging investor confidence.
Rant over :)
Been updated on the website now
https://www.provexis.com/shareholder-information/major-shareholders/
I am not reading too much into it as it was only around 13 million shares sold and dropped from 6.48 to 5.9%
But...... What if it had been 50 million 80 million 120 million?
The regulations are there for a reason and should be followed by all.
Just for info
In July 2010 DSM sold 52 million shares leaving them with 143,769,230 shares and 12% of the company.
https://www.investegate.co.uk/announcement/rns/provexis--pxs/notification-of-major-interes/2438343
Their next holding RNS was May 2017 down from 8.2 to 7.9% holding the same amount of shares.
https://www.investegate.co.uk/announcement/rns/provexis--pxs/holding-s-in-company/5140966
No other holdings RNS as far as i can see.
Today we find out that they have sold just under 13 million since May 2017 and gone down from 6.48% to 5.9%
Surly DSM have missed a lot of Holding RNS's
Wonder if we will get one after the 5th of April.
Don't get me wrong, I am happy with todays news and the fact that DSM have increased their holding but they should be informing the market when a threshold is reached.
According to the RNS DSM have 5.9% so would have crossed a threshold. How that works because they are outside the UK I don't know. A threshold of 5%???
If the not in public hands info was updated with the wrong % holding of DSM then this info is wrong as well 🤔
Yes Provexis has not been on the DSMV website portfolio for a very, very long time